ResearcherRutgers, The State University of New JerseyActive in the last 2 years
Xi Zheng
Matched on ORCID iD 0000-0001-7522-631X; OpenAlex author ID A5022457658. Sources: OpenAlex.
Their work
- Papers
- 11 (first author 3, last author 6)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 22
2012: 1 paper · 2013: none · 2014: 1 paper · 2015: 3 papers · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: 2 papers · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper
Papers 11
- Inhibitory effect of liriopesides B in combination with gemcitabine on human pancreatic cancer cells. Last author DOI 10.1016/j.bioorg.2023.106937↗
- Effects of atorvastatin in combination with celecoxib and tipifarnib on proliferation and apoptosis in pancreatic cancer sphere-forming cells. Last author DOI 10.1016/j.ejphar.2020.173840↗
- (3E,5E)-3,5-Bis(pyridin-3-methylene)-tetrahydrothiopyran-4-one enhances the inhibitory effect of gemcitabine on pancreatic cancer cells. Co-author DOI 10.1016/j.bioorg.2020.104022↗
- Celecoxib combined with salirasib strongly inhibits pancreatic cancer cells in 2D and 3D cultures. Last author DOI 10.7150/ijms.47546↗
- Elevated Transient Receptor Potential Melastatin 8 (TRPM8) Expression Is Correlated with Poor Prognosis in Pancreatic Cancer. First author DOI 10.12659/msm.909968↗
- Natural Products as Adjunctive Treatment for Pancreatic Cancer: Recent Trends and Advancements. Last author DOI 10.1155/2017/8412508↗
- Metformin combined with aspirin significantly inhibit pancreatic cancer cell growth in vitro and in vivo by suppressing anti-apoptotic proteins Mcl-1 and Bcl-2. First author DOI 10.18632/oncotarget.4126↗
- Combination of 12-O-tetradecanoylphorbol-13-acetate with diethyldithiocarbamate markedly inhibits pancreatic cancer cell growth in 3D culture and in immunodefi… Last author DOI 10.3892/ijmm.2015.2163↗
- MicroRNA‑506 participates in pancreatic cancer pathogenesis by targeting PIM3. First author DOI 10.3892/mmr.2015.4109↗
- A triple combination of atorvastatin, celecoxib and tipifarnib strongly inhibits pancreatic cancer cells and xenograft pancreatic tumors. Last author DOI 10.3892/ijo.2014.2350↗
- Effects of 12-O-tetradecanoylphorbol-13-acetate in combination with gemcitabine on Panc-1 pancreatic cancer cells cultured in vitro or Panc-1 tumors grown in i… Co-author DOI 10.3892/ijo.2012.1651↗
Closest collaborators
The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xuetao Xu · 4 shared papers, 2020–2024 · strength 0.51
- Paper Inhibitory effect of liriopesides B in combination with gemcitabine on human pancreatic cancer cells. DOI 10.1016/j.bioorg.2023.106937↗
- Paper Effects of atorvastatin in combination with celecoxib and tipifarnib on proliferation and apoptosis in pancreatic cance… DOI 10.1016/j.ejphar.2020.173840↗
- Paper Celecoxib combined with salirasib strongly inhibits pancreatic cancer cells in 2D and 3D cultures. DOI 10.7150/ijms.47546↗
- Dongli Li · 4 shared papers, 2015–2024 · strength 0.44
- Paper Inhibitory effect of liriopesides B in combination with gemcitabine on human pancreatic cancer cells. DOI 10.1016/j.bioorg.2023.106937↗
- Paper Celecoxib combined with salirasib strongly inhibits pancreatic cancer cells in 2D and 3D cultures. DOI 10.7150/ijms.47546↗
- Paper (3E,5E)-3,5-Bis(pyridin-3-methylene)-tetrahydrothiopyran-4-one enhances the inhibitory effect of gemcitabine on pancrea… DOI 10.1016/j.bioorg.2020.104022↗
- Panpan Wu · 2 shared papers, 2020–2024 · strength 0.29
- Paper Inhibitory effect of liriopesides B in combination with gemcitabine on human pancreatic cancer cells. DOI 10.1016/j.bioorg.2023.106937↗
- Paper (3E,5E)-3,5-Bis(pyridin-3-methylene)-tetrahydrothiopyran-4-one enhances the inhibitory effect of gemcitabine on pancrea… DOI 10.1016/j.bioorg.2020.104022↗
- Xiao Wang · 2 shared papers, 2020–2021 · strength 0.22
- Paper Effects of atorvastatin in combination with celecoxib and tipifarnib on proliferation and apoptosis in pancreatic cance… DOI 10.1016/j.ejphar.2020.173840↗
- Paper (3E,5E)-3,5-Bis(pyridin-3-methylene)-tetrahydrothiopyran-4-one enhances the inhibitory effect of gemcitabine on pancrea… DOI 10.1016/j.bioorg.2020.104022↗
- Kun Zhang · 2 shared papers, 2020–2021 · strength 0.22
- Paper Effects of atorvastatin in combination with celecoxib and tipifarnib on proliferation and apoptosis in pancreatic cance… DOI 10.1016/j.ejphar.2020.173840↗
- Paper (3E,5E)-3,5-Bis(pyridin-3-methylene)-tetrahydrothiopyran-4-one enhances the inhibitory effect of gemcitabine on pancrea… DOI 10.1016/j.bioorg.2020.104022↗
- Wing‐Leung Wong · 1 shared paper, 2024 · strength 0.18
- Fan Zhang · 1 shared paper, 2024 · strength 0.18
- Peng Hong · 1 shared paper, 2024 · strength 0.18
- Shouwang Cai · 2 shared papers, 2015–2018 · strength 0.14
- Hua-Bao Jiao · 2 shared papers, 2015–2018 · strength 0.14
- Ziman Zhu · 2 shared papers, 2015–2018 · strength 0.14
- Bin Hu · 2 shared papers, 2015–2018 · strength 0.14
- Jundong Du · 2 shared papers, 2015–2018 · strength 0.14
- Qingxi Yue · 1 shared paper, 2017 · strength 0.09
- Yong-liang Chen · 1 shared paper, 2018 · strength 0.09
- Allan H. Conney · 2 shared papers, 2012–2014 · strength 0.07
- Paper A triple combination of atorvastatin, celecoxib and tipifarnib strongly inhibits pancreatic cancer cells and xenograft … DOI 10.3892/ijo.2014.2350↗
- Paper Effects of 12-O-tetradecanoylphorbol-13-acetate in combination with gemcitabine on Panc-1 pancreatic cancer cells cultu… DOI 10.3892/ijo.2012.1651↗
- Xiang‐Lin Tan · 1 shared paper, 2015 · strength 0.05
- Qing Xu · 1 shared paper, 2015 · strength 0.05
- Wen Yue · 1 shared paper, 2015 · strength 0.05
- Darren R. Carpizo · 1 shared paper, 2015 · strength 0.05
- Huarong Huang · 1 shared paper, 2015 · strength 0.05
- Ning Ding · 1 shared paper, 2014 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.